PuSH - Publication Server of Helmholtz Zentrum München

de Guia, R.M.* ; Rose, A.J.* ; Sommerfeld, A.* ; Seibert, O.* ; Strzoda, D.* ; Zota, A.* ; Feuchter, Y.* ; Krones-Herzig, A.* ; Sijmonsma, T.* ; Kirilov, M.* ; Sticht, C.* ; Gretz, N.* ; Dallinga-Thie, G.M.* ; Diederichs, S.* ; Klöting, N.* ; Blüher, M.* ; Berriel Diaz, M.* ; Herzig, S.*

microRNA-379 couples glucocorticoid hormones to dysfunctional lipid homeostasis.

EMBO J. 34, 344-360 (2015)
DOI PMC
Open Access Green as soon as Postprint is submitted to ZB.
In mammals, glucocorticoids (GCs) and their intracellular receptor, the glucocorticoid receptor (GR), represent critical checkpoints in the endocrine control of energy homeostasis. Indeed, aberrant GC action is linked to severe metabolic stress conditions as seen in Cushing's syndrome, GC therapy and certain components of the Metabolic Syndrome, including obesity and insulin resistance. Here, we identify the hepatic induction of the mammalian conserved microRNA (miR)-379/410 genomic cluster as a key component of GC/GR-driven metabolic dysfunction. Particularly, miR-379 was up-regulated in mouse models of hyperglucocorticoidemia and obesity as well as human liver in a GC/GR-dependent manner. Hepatocyte-specific silencing of miR-379 substantially reduced circulating very-low-density lipoprotein (VLDL)-associated triglyceride (TG) levels in healthy mice and normalized aberrant lipid profiles in metabolically challenged animals, mediated through miR-379 effects on key receptors in hepatic TG re-uptake. As hepatic miR-379 levels were also correlated with GC and TG levels in human obese patients, the identification of a GC/GR-controlled miRNA cluster not only defines a novel layer of hormone-dependent metabolic control but also paves the way to alternative miRNA-based therapeutic approaches in metabolic dysfunction.
Altmetric
Additional Metrics?
[➜Log in]
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Corresponding Author
Keywords Ldlr ; Lsr ; Vldl Triglyceride ; Glucocorticoid Signalling ; Mirna‐379
ISSN (print) / ISBN 0261-4189
e-ISSN 1460-2075
Journal EMBO Journal, The
Quellenangaben Volume: 34, Issue: 3, Pages: 344-360 Article Number: , Supplement: ,
Publisher Wiley
Publishing Place Heidelberg, Germany
Non-patent literature Publications
Reviewing status Peer reviewed
Institute(s) Institute of Diabetes and Cancer (IDC)